Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area
Country
Application Due Date
BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
Release Date:
Review Process: Pfizer Internal
Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Title
Grant Type
Focus Area
Country
Application Due Date
Cardiac Transthyretin Amyloid (ATTR) Fellowship
Release Date:
Partner: International Society of Amyloidosis
Review Process: Expert Review Panel
Fellowship Rare Disease All
Early Diagnosis of Invasive Fungal Infections(Europe, Australia, New Zealand, Korea and Japan)
Release Date:
Review Process: Pfizer Internal
Research Hospital All
Pfizer and RCNi – Providing Access to Learning Resources for Nurses in Emerging Markets Asia
Release Date:
Partner: RCNi
Review Process: Expert Review Panel
Education Support for the Professions Hong Kong, India, Indonesia, Malaysia, Pakistan, Philippines, Singapore, Taiwan, Thailand, Vietnam
Improving Real-World Evidence & Data Generation Skills in Latin America
Release Date:
Review Process: Pfizer Internal
Education Support for the Professions All
Optimizing Venous Thromboembolism Management in Latin America
Release Date:
Review Process: Pfizer Internal
Quality Improvement Internal Medicine All
Alopecia Areata, Atopic Dermatitis and Vitiligo (Global)
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology All
Relapsed/Refractory Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Antimicrobial Stewardship (AMS) Programs to Address Health Inequities in Resource Limited Settings
Release Date:
Partner: Global Bridges at Mayo Clinic
Review Process: Expert Review Panel
Quality Improvement Hospital All
Increase HCP knowledge of Gene Therapy management
Release Date:
Review Process: Pfizer Internal
Education Rare Disease China
Burden of Pneumococcal Disease - Analyzing Local Surveillance Data (Asia, Africa, Latin America, and Middle East)
Release Date:
Review Process: Pfizer Internal
Research Vaccines All
Pre-clinical & Translational Research in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Research Oncology All
Best Practices in HR+HER2-Metastatic Breast Cancer Medical Management Latin America,Africa,Middle East,Asia Pacific except China
Release Date:
Review Process: Pfizer Internal
Education Oncology All